Cambridge Investment Research Advisors
APYX icon

Cambridge Investment Research Advisors’s Apyx Medical APYX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-22,995
Closed -$149K – 2282
2018
Q4 		$149K Sell
22,995
-2,400
-9% -$14.5K ﹤0.01% 1986
2018
Q3 		$180K Sell
25,395
-3,000
-11% -$16.7K ﹤0.01% 2075
2018
Q2 		$124K Buy
28,395
+5,000
+21% +$18.4K ﹤0.01% 2088
2018
Q1 		$69K Buy
+23,395
New +$60.2K ﹤0.01% 2081

Other funds holding APYX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors's APYX Position: Q1 2019 in Review

Cambridge Investment Research Advisors sold out of Apyx Medical (APYX) in Q1 2019, closing a stake of 22,995 shares — an estimated $149K sold.

Cambridge Investment Research Advisors first reported a position in APYX in Q1 2018 and held it in 4 quarters. The position peaked at $180K in Q3 2018. 78 funds tracked by Wall St. Rank hold APYX as of Q1 2019.

  • Cambridge Investment Research Advisors reported no remaining Apyx Medical position as of Q1 2019 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 22,995 Apyx Medical shares in Q1 2019, an estimated $149K.
  • Cambridge Investment Research Advisors first reported a position in Apyx Medical in Q1 2018 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's Apyx Medical position peaked at $180K in Q3 2018.
  • 78 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2019, filed 8 May 2019.